Market Highlights: Lifestyle drug is basically an imprecise term which is been commonly applied to the medications which treat the non–life-threatening and some of the non-painful conditions such as baldness, erectile dysfunction, wrinkles, or acne, that the speaker perceives as minor conditions of medical relative to others or as either not medical problems at all. This is sometimes intended as a pejorative, bearing the implication which the scarce medical research resources have been allocated to develop such drugs. A large number of lifestyle drugs have been approved by the FDA and other regulatory bodies of different countries for some skin conditions and disorders related to lifestyle. Some of the indications such as pigmentation, acne, wrinkles, psoriasis and many others can be treated by such drugs. The market study is being classified by Type (Depression, Dermatology, Sexual dysfunction and Obesity), by Application (Children, Adults and Senior Citizens) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Lifestyle Drugs are ALLERGAN PLC (Ireland), BMS (United States), Eli Lilly (United States), Pfizer (United States), Acerus Pharmaceuticals (Canada), Alkermes (Ireland), Amorepacific (South Korea), AndroScience (Slovakia), AstraZeneca (United Kingdom) and Avanir Pharmaceuticals (United States).
Key Questions Answered in the Report What will the Lifestyle Drugs Market size and the growth rate be in Future? What are the key factors driving the Lifestyle Drugs Market? What are the key market trends and macro-economic impacting the growth of the Lifestyle Drugs Market? What are the challenges to market growth? Who are the key vendors in the Lifestyle Drugs Market? What are the market opportunities and threats faced by the vendors in the Lifestyle Drugs Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the Lifestyle Drugs Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Lifestyle Drugs market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Lifestyle Drugs market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Lifestyle Drugs Manufacturers, Traders and Distributors of Lifestyle Drugs, Research and Development Institutes, Potential Investors, Nationalized Laboratory, Government and Research Organizations, Trade Associations and Industry Bodies, Commercial Research & Development Institutions and Others. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.